abstract |
The present invention relates to the following general formula (I): Novel GPR119 agonists, tautomers thereof, stereoisomers thereof, pharmaceutically acceptable salts thereof, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine, and To the use of intermediates involved in the preparation of |